Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
28 Februari 2026, 06:33:36
Alcohol
Alcohol Use Disorder (AUD) is a chronic relapsing condition characterized by impaired control over alcohol consumption despite harmful physical, psychological, or social consequences. In individuals with physiological dependence, sudden reduction or cessation of alcohol intake leads to alcohol withdrawal syndrome, which ranges from mild symptoms to severe life-threatening complications such as seizures and delirium tremens.
Alcohol detoxification involves supervised medical management aimed at preventing withdrawal complications, reducing mortality risk, and preparing patients for long-term rehabilitation and relapse prevention.
Risk Factors
Chronic heavy alcohol consumption
Previous alcohol withdrawal episodes
History of withdrawal seizures or delirium tremens
Coexisting psychiatric illness
Liver disease or chronic medical illness
Malnutrition
Older age
Concurrent substance use
Poor social support
Abrupt cessation after prolonged intake
Signs and Symptoms
Early Withdrawal Symptoms (6–24 hours)
Insomnia
Tremors
Anxiety
Chills
Sweating
Headache
Nausea or vomiting
Palpitations
Moderate Withdrawal
Increased blood pressure
Tachycardia
Irritability
Restlessness
Mild confusion
Severe Withdrawal
Seizures
Hallucinations
Severe agitation
Delirium Tremens
Diagnostic Criteria
Diagnosis is clinical and based on:
Recent reduction or cessation of prolonged alcohol use accompanied by ≥2 of the following:
Insomnia
Tremors
Anxiety
Autonomic hyperactivity
Nausea or vomiting
Psychomotor agitation
Transient hallucinations
Seizures
Symptoms must cause clinically significant distress or functional impairment and not be explained by another medical condition.
Investigations
Baseline Laboratory Tests
Blood glucose level
Full blood count
Electrolytes
Liver function tests
Renal function tests
Serum magnesium
Blood alcohol level
Additional Assessment
ECG in high-risk patients
Screening for coexisting infections
Nutritional assessment
Mental health evaluation
Management
Management goals include:
Prevention of severe withdrawal
Stabilization of vital functions
Correction of nutritional deficiencies
Preparation for long-term abstinence
Non-Pharmacological Management
Support groups encouraging abstinence
Psychological counselling
Motivational interviewing
Family and community support
Inpatient rehabilitation programs when necessary
Safe and low-stimulation environment
Adequate hydration and nutrition
Pharmacological Management
Vitamin Replacement
Chronic alcohol use commonly causes thiamine deficiency leading to neurological complications.
Thiamine 300 mg IM every 24 hours(for prevention of central nervous system complications)
Benzodiazepine Therapy (Detoxification)
Option 1 – Diazepam Regimen (Inpatient care only)
Diazepam 10 mg orally every 4–6 hours during first 24 hours
Gradually reduce dose by 20% over 3–5 days
OR
Option 2 – Chlordiazepoxide Regimen
Chlordiazepoxide 20–60 mg orally daily in divided doses
Gradual taper over approximately 1 month
Benzodiazepines reduce:
Withdrawal severity
Seizure risk
Progression to delirium tremens
Relapse Prevention Following Detoxification
Long-term treatment is essential after successful detoxification.
Pharmacotherapy
Naltrexone 50 mg orally once daily
Reduces alcohol craving
Decreases relapse risk
Psychosocial Interventions
Cognitive Behavioural Therapy (CBT)
Alcohol abstinence programs
Peer recovery groups
Behavioral relapse-prevention strategies
Complications
Withdrawal seizures
Delirium Tremens
Wernicke encephalopathy
Korsakoff syndrome
Liver cirrhosis
Cardiomyopathy
Depression and suicide risk
Prevention
Screening for harmful alcohol use in primary care
Early intervention programs
Public education on alcohol-related harm
Gradual medically supervised cessation
Nutritional supplementation in high-risk individuals
Continuous rehabilitation and follow-up care
Prognosis
Outcomes improve significantly with structured detoxification followed by long-term rehabilitation. Relapse is common without psychosocial support and pharmacologic relapse prevention.
Patient Education
Alcohol dependence is a treatable medical condition
Sudden alcohol cessation without supervision may be dangerous
Medication-assisted detox reduces complications
Long-term recovery requires behavioural support
Continued follow-up prevents relapse
References
Ministry of Health. Standard Treatment Guidelines (STG). 2023 Edition.
World Health Organization. Management of Alcohol Use Disorders. Geneva: WHO; 2019.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Washington DC: APA; 2013.
National Institute for Health and Care Excellence (NICE). Alcohol-use disorders: diagnosis, assessment and management. London: NICE; 2017.
Soyka M, et al. Pharmacological treatment of alcohol dependence: a review. CNS Drugs. 2017;31(6):443-460.
